A detailed history of Kula Investments, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Kula Investments, LLC holds 36,199 shares of AUPH stock, worth $317,465. This represents 0.1% of its overall portfolio holdings.

Number of Shares
36,199
Holding current value
$317,465
% of portfolio
0.1%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$5.94 - $11.27 $215,022 - $407,962
36,199 New
36,199 $397 Million

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.24B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Kula Investments, LLC Portfolio

Follow Kula Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kula Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kula Investments, LLC with notifications on news.